 |
인쇄하기
취소
|
Korean drug makers to release 5 new medicines this year
Korean pharmaceutical firms will launch five new drugs on the domestic market this year following 12 new items, such as Zydena, according to the Korea Drug Research Association.
New medicines that are to be commercialized within this year after completion of their Phase III clinical trials include Gene Recombinant Factor VIII (hemophilia) by Green Cross Corporation, AG1321001 (anti-asthma a...
New medicines that are to be commercialized within this year after completion of their Phase III clinical trials include Gene Recombinant Factor VIII (hemophilia) by Green Cross Corporation, AG1321001 (anti-asthma a...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.